ideasIdea

Open the barrier so engineered immune cells can enter the brain

Engineered immune cells given by drip rarely reach brain tumours. Briefly opening the barrier with focused ultrasound at the right moment may let them in.

Most focused ultrasound work has aimed at small molecules and antibodies, but preclinical studies show increased trafficking of natural killer cells and CAR-T cells into brain tumours after sonication. Timing matters because the barrier reseals within hours, so the infusion schedule must be matched to the opening window.

Hypothesis

Sonication immediately before or during cell infusion increases intratumoural engineered cell density in the brain by at least fivefold compared with infusion alone, measurable by imaging or by post-mortem and resection tissue analysis.

Rationale

Cell therapy in brain tumours currently requires direct intratumoural or intraventricular delivery, which limits repeat dosing. If systemic infusion could be made to work, cell therapy in the brain would become far more practical.

What would test it

Large-animal or first-in-human study pairing radiolabelled or reporter-gene-tagged cell infusion with and without sonication, quantifying brain cell delivery as the primary endpoint.

Maturity

preclinical evidence

Who has to act

research

Cost to try

Medium ($1M to $50M)

Years to first evidence

Bottlenecks it attacks

The brain: barrier and sanctuary · Most drugs cannot cross into the brain, so brain tumours and brain metastases lag every other site.
Manufacturing cost and time for living and radioactive medicines · Cell therapies take weeks to make for one patient and cost hundreds of thousands of dollars. Isotopes run short.

Connected

11top

Pages like this

not linked directly; found by shared links

Open the barrier so engineered immune cells can enter the brain

Connected

Pages like this

cancers

technologies

targets

companies

bottlenecks